Objective: To establish whether then has been any rise in the prevalence of
non-albicans Candida species isolated from vaginal swabs since the introdu
ction of "over the counter" antifungal treatments.
Method: A retrospective review looking at all positive vaginal yeast isolat
es collected from women attending one genitourinary medicine clinic during
the 6 year period from 1993 to 1998 inclusive. All positive vaginal yeast i
solates were included, regardless of whether or not the patients were sympt
omatic. Isolates from HIV positive women were excluded from the analysis.
Result: No increase in non-albicans vaginal yeast isolates was shown during
the period studied. The proportion of non-albicans yeasts remained constan
t at approximately 5% of the total yeasts isolated. The most common non-alb
icans yeast isolated was C glabrata.
Conclusion: There is no evidence from this study to suggest that the increa
sing use of "over the counter" antifungal treatment has selected for atypic
al, possibly inherently azole resistant, strains of vaginal yeasts in HIV s
eronegative women.